CAPR - capricor.com Debt to Book Capitalization Ratio

Capricor Therapeutics (CAPR) relies on a complex low-temperature biomaterial transport system, which protects raw materials and sustains high profits. This chart of stock quotes confirms the asset's dynamics, with a metric of 0.36. The company is building a scientific ecosystem around exosomes and cellular treatment for cardiovascular pathologies while adhering to strict laboratory waste disposal standards.

CAPR (Capricor Therapeutics, Inc.) Debt to Book Value history from 07/04/2022 to 10/27/2026

capricor.com (CAPR) - metric breakdowns and financial figures

- price and consensus price forecast:

Stock Price Capricor Therapeutics, Inc.|CAPR - Analyst Consensus Forecast

- market capitalization data:

Market Value Capricor Therapeutics, Inc.|CAPR - Value Adjusted for Debt and Cash

- book capitalization data:

Net Assets per Single Share Capricor Therapeutics|CAPR - Company Net Assets|Market Capitalization to Book Value Ratio capricor.com|CAPR - Company Total Assets

- debt and liquidity data:

Total Debt to Equity Ratio Capricor Therapeutics|CAPR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Capricor Therapeutics, Inc.|CAPR - Company Aggregate Debt|Debts to Book Capitalization Capricor Therapeutics, Inc.

Fundamental company analysis:Capricor - CAPR

Core merchandise of Capricor Therapeutics, Inc.

When screening business quality, an investor assesses a company's stability by comparing total liabilities to its equity. This calculated ratio determines the proportion of borrowed funds within the balance sheet structure, which for Capricor Therapeutics (CAPR) confirms management's financial discipline in implementing Duchenne therapy, reflecting this indicator of capital structure risk on the balance sheet.

Competitors of Capricor Therapeutics (CAPR)